DRUG TARGETOR

Build drug-gene interaction networks using GWAS data

Drug Targetor: genetics-driven drug-target networks

This website harnesses results from genome-wide association studies (GWAS), and drug bioactivity data, to prioritize drugs and targets for a given phenotype. Drug Targetor networks are constructed using genetically scored drugs and genes, connected by the type of drug-target or drug-gene interaction.

Contact Info

For any information or request, contact Héléna A. Gaspar, PhD, King's College London.

Email: helena.gaspar@kcl.ac.uk

Home Website: lovingscience.com